Icon

EFUDEX (nda016831)- (5%)

FLUOROURACIL EXTROVIS
5%
No No
Expired Expired
None None
None No
EFUDEX is recommended for the topical treatment of multiple actinic or solar keratoses. In the 5% strength, it is also useful in the treatment of superficial basal cell carcinomas when conventional methods are impractical, such as with multiple lesions or difficult treatment sites. Safety and efficacy in other indications have not been established.
3 0 3
Total Other Developers 5
Drugs with Suitability No
5% ** ** - - 3
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ** ****** **** ** ********* ************** *************, *** *********** *** ******* ****, *********, ******* (**) *****, ****** ****** (***) ***
****** **** **** ************** ********** ***. *********** ** ******* ******, ***** ***, *******, ****** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. ***/***-****** / **** **.***/****-*********** , *******-***** ******* , ****** -******, ******, *********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.